Task: Answer the multiple choice question.
Question: Which drug exhibits a 5.401\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) Cc1ccc2nc(SCC(=O)N3CCCCC3)nc(=O)n2c1
b.) Cc1nnc(C)c2c(C)n(-c3ccccc3N)c(C)c12
c.) CSc1nnc2c(n1)c(C)nn2-c1cccc(C)c1
Answer: b. Cc1nnc(C)c2c(C)n(-c3ccccc3N)c(C)c12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nnc(C)c2c(C)n(-c3ccccc3N)c(C)c12
Cc1nnc(C)c2c(C)n(-c3ccccc3N)c(C)c12
2-(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)aniline